The following is a list of initial public offerings planned for the coming week. Sources include SEC filings and Renaissance Capital, Greenwich, Conn. (www.renaissancecapital.com).
Cancer Genetics Inc.
(Rutherford, N.J.) 4 million shares, priced $11 to $13, managed by William Blair and Baird. Proposed Nasdaq symbol: CGIX. Business: Offers proprietary genomic tests to improve the diagnosis, prognosis and treatment of cancer.
(Menlo Park, Calif.) 337.4 million class A shares, priced $28 to $35, managed by Morgan Stanley, J.P. Morgan, and Goldman Sachs. Proposed Nasdaq symbol: FB. Business: Operates the world's leading social networking platform. This issue is scheduled to price Thursday evening, May 17, and trade Friday, May 18.